Cancer survival is 13% lower for people living in rural and remote Australia. A new national Optimal Care Pathway sets a shared standard for the best possible cancer care, wherever someone lives.
Gain practical insights into understanding and responding to the evolving needs of people living with CML, from diagnosis through treatment and beyond.
In this webinar recording, Dr Raquel Ruiz Araujo shares practical insights into recognising and managing these reactions, including those caused by EGFR inhibitors.
From 1 October 2026, Triptorelin 3.75mg (Diphereline®) will become available on the PBS for the treatment of a range of women’s health conditions, including breast cancer, endometriosis and uterine fibrosis.
Discover emerging research that shines a light on the financial burden faced by people living with cancer and how these pressures shape quality of life, treatment experiences, and health outcomes.
